Skip to main content

Cellular Mechanism of Action of Directly Acting Vasodilator Drugs

  • Chapter
Vasodilators in Chronic Heart Failure
  • 65 Accesses

Abstract

Directly acting vasodilator drugs relax vascular smooth muscle by interference with the cellular process of excitation-contraction coupling. Although pharmacological antagonists, mostly of the competitive type, such as α-adrenoceptor blockers, conform with this definition, they are usually not included in the group of vasodilators.

Supported by the Deutsche Forschungsgemeinschaft, SFB 90 (Kardiovasculäres System) Heidelberg, Federal Republic of Germany

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59: 606–718

    PubMed  CAS  Google Scholar 

  • Chevillard C, Mathieu MN, Saiag B, Worcel M (1980) Hydralazine: effect on the outflow of nor-adrenaline and mechanical responses evoked by sympathetic nerve stimulation of the rat tail artery. Br J Pharmacol 69: 415–420

    PubMed  CAS  Google Scholar 

  • Haeusler G, Gerold M (1979) Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine, and minoxidil. NaunynSchmiedebergs Arch Pharmacol 310: 155–167

    Article  CAS  Google Scholar 

  • Ito Y, Suzuki J, Kuriyama H (1978) Effects of sodium nitroprusside on smooth muscle cells of rabbit pulmonary artery and portal vein. J Pharmacol Exp Ther 207: 1022–1031

    PubMed  CAS  Google Scholar 

  • Johnson JD, Vaghy PL, Crouch TH, Potter JD, Schwartz A (1982) A hypothesis for the mechanism of action of some of the Ca2+ antagonist drugs: calmodulin as a receptor. Advances in Pharmacology and Therapeutics II. Vol 3. In: Yoshida H, Hagihara Y, Ebashi S (eds) Cardiorenal and cell pharmacology, Pergamon Press, Oxford New York Toronto Sydney Paris Frankfurt, pp 121–138

    Google Scholar 

  • Kreye VAW (1980) Sodium nitroprusside: approaches towards the elucidation of its mode of action. Trends Pharmacol Sci 1: 384–388

    Article  CAS  Google Scholar 

  • Kreye VAW (1981) Role of the membrane potential in the function of vascular smooth muscle. In: Vanhoutte PM, Leusen I (eds) Vasodilatation. Raven Press, New York, pp 299–305

    Google Scholar 

  • Kreye VAW, Baron GD, Lüth JB, Schmidt-Gayk H (1975) Mode of action of sodium nitroprusside on vascular smooth muscle. Naunyn-Schmiedebergs Arch Pharmakol 288: 381–402

    Article  CAS  Google Scholar 

  • Kreye VAW, Kern R, Schleich I (1977) Chloride efflux from noradrenaline-stimulated rabbit aorta inhibited by sodium nitroprusside and nitroglycerine. In: Casteels R, Godfriend T, Rüegg JC (eds) Excitation-contraction coupling in smooth muscle. Elsevier, North-Holland Biomedical Press, Amsterdam New York, pp 145–150

    Google Scholar 

  • Kreye VAW, Schlicker E (1980) Effects of vasodilator drugs alkaline phosphatase, and cyclic AMP-dependent protein-kinase on the 45 calcium uptake of sarcolemmal microsomes from human umbilical arteries. Br J Pharmacol 70: 537–544

    PubMed  CAS  Google Scholar 

  • Kukovetz WR, Holzmann S, Wurm A, Pöck G (1979) Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn-Schmiedebergs Arch Pharmacol 310: 129–138

    Article  PubMed  CAS  Google Scholar 

  • McLean (1978) J Pharmacol Exp Ther 205: 418–425

    PubMed  CAS  Google Scholar 

  • Perry SV, Grand RJA (1979) Mechanisms of contraction and the specialized protein components of smooth muscle. Br Med Bull 35: 219–226

    PubMed  CAS  Google Scholar 

  • Rüegg JC, Sparrow MP, Mrwa U (1981) Cyclic-AMP mediated relaxation of chemically skinned fibres of smooth muscle. Pflügers Arch 390: 198–201

    Article  PubMed  Google Scholar 

  • Schultz K-D, Böhme E, Kreye VAW, Schultz GD (1979) Relaxation of hormonally stimulated smooth muscular tissues by the 8-bromo derivative of cyclic GMP. Naunyn-Schmiedebergs Arch Pharmacol 306: 1–9

    Article  PubMed  CAS  Google Scholar 

  • Worcel M (1978) Relationship between the direct inhibitory effects of hydralazine and propyldazine on arterial smooth muscle contractility and sympathetic innervation. J Pharmacol Exp Ther 207: 320–330

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kreye, V.A.W. (1983). Cellular Mechanism of Action of Directly Acting Vasodilator Drugs. In: Just, H., Bussmann, WD. (eds) Vasodilators in Chronic Heart Failure. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68605-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68605-4_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-68607-8

  • Online ISBN: 978-3-642-68605-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics